Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_501b1943a72ec7b9fcfc1ab0cf6cc8ba |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
filingDate |
2015-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7dc33c92c167cc72f5aafd2a6dc7e98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_050b1cfec48bd5aab84c31bd91a3ab10 |
publicationDate |
2015-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2950128-A1 |
titleOfInvention |
Fatty acid bile acid conjugates for treatment of lipodystrophy |
abstract |
The present disclosure relates generally methods of treating and/or reducing risk of lipodystrophy using compositions comprising at least one fatty-acid/bile-acid conjugate (FABAC). According to some embodiments, the present disclosure provides methods of treating HIV-associated lipodystrophy using said FABACs. |
priorityDate |
2014-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |